These findings suggest that the addition of urinary PCA3 to the current routine diagnostic protocols in Ghana can improve the outcome of prostate cancer screening and reduce the number of patients who may have to go through unnecessary invasive biopsy procedures. This evidence concerns the gene PCA3 and Familial prostate cancer.